Physician profile
Daniel M Kurtzman
NPI 1588753693
$6,539.26
in general payments reported to CMS, 2019-2025
24 companies · $1,213 in 2025
The $1,213 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $888 · 2020: $1,190 · 2021: $909 · 2022: $736 · 2023: $694 · 2024: $909 · 2025: $1,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385 · Travel and Lodging: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,384.87 |
| Travel and Lodging | $431.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $2,317.00 | 2019-2025 | |
| Stryker Corporation | $690.94 | 2019-2025 | Scopis Ent |
| Alk-Abello, INC | $543.24 | 2019-2023 | Odactra, Ragwitek, Grastek |
| Glaxosmithkline, LLC. | $490.72 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $409.11 | 2019-2025 | Dupixent |
| Acclarent, INC | $352.63 | 2019-2023 | Acclarent Aera |
| Genzyme Corporation | $344.16 | 2021-2025 | |
| Intersect Ent, INC. | $322.51 | 2019-2021 | |
| Aerin Medical INC. | $210.71 | 2021-2025 | |
| Xoran Technologies LLC | $176.65 | 2019 | |
| Medtronic, INC. | $157.32 | 2023-2024 | Sinuva, Stealthstation S8 Platform, Nuvent |
| Smith+Nephew, INC. | $120.89 | 2019-2025 | |
| Inspire Medical Systems, INC. | $69.57 | 2024-2025 | Inspire |
| Neurent Medical Limited | $67.45 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Integra Lifesciences Corporation | $45.29 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $38.20 | 2019 | |
| Paratek Pharmaceuticals, INC. | $35.80 | 2025 | Nuzyra |
| Astrazeneca Pharmaceuticals Lp | $33.44 | 2019 | |
| Amgen INC. | $28.39 | 2025 | Tezspire |
| Medtronic USA, INC. | $23.99 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.18 | 2019 | |
| Merck Sharp & Dohme LLC | $14.55 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.72 | 2019 | |
| Cook Medical LLC | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kurtzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.